Related Experiment Video
Updated: Feb 7, 2026

11:48
Detection of Alternative Splicing During Epithelial-Mesenchymal Transition
Published on: October 9, 2014
13.4K
Alternative splicing in cardiomyopathy
1Centre for Cardiovascular Science, Queen's Medical Research Institute, University of Edinburgh, 47 Little France Crescent, Edinburgh, EH16 4TJ, UK. a.beqqali@ed.ac.uk.
Biophysical Reviews
|July 28, 2018
Summary
Alternative splicing generates diverse proteins in the heart, crucial for development and disease. Specific cardiac splice factors impact heart function and cardiomyopathies.
Area of Science:
- Molecular Biology
- Genetics
- Cardiology
Background:
- Alternative splicing is a key mechanism for generating transcriptomic and proteomic diversity from the genome.
- In the heart, alternative splicing functions as a critical layer of post-transcriptional gene regulation.
- Next-generation sequencing technologies have highlighted alternative splicing's role in cardiac development and disease.
Purpose of the Study:
- To review current knowledge on alternative splicing in the heart.
- To focus on factors controlling cardiac alternative splicing.
- To examine the role of these factors in cardiomyopathies and heart failure.
Main Methods:
- Literature review of studies on cardiac alternative splicing.
- Analysis of the impact of specific cardiac splice factors (e.g., RNA-binding motif protein 20 and 24).
- Examination of the connection between splicing dysregulation and heart conditions.
Main Results:
- Alternative splicing significantly contributes to cardiac functional properties.
- Identification of key cardiac splice factors provides insight into splicing mechanisms.
- Dysregulation of cardiac alternative splicing is linked to cardiomyopathies and heart failure.
Conclusions:
- Alternative splicing is a vital process in cardiac biology, influencing development and disease.
- Cardiac splice factors are crucial regulators of heart function and disease progression.
- Understanding cardiac alternative splicing offers potential therapeutic targets for heart failure.
Related Concept Videos
Alternative RNA Splicing
25.2K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
25.2K
Alternative RNA Splicing
5.2K
5.2K
RNA Splicing
60.7K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
60.7K
Cardiomyopathy II: Dilated Cardiomyopathy
575
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
575
Cardiomyopathy III: Hypertrophic Cardiomyopathy
503
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
503
Cardiomyopathy IV: Restrictive Cardiomyopathy
558
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
558

